Orion Office REIT ONL Income (Loss) From Equity Method Investments And Equity Method Investment, Other-than-Temporary Impairment
Income (Loss) From Equity Method Investments And Equity Method Investment, Other-than-Temporary Impairment at other companies
Other financials
Where this comes from
Reported directly by Orion Office REIT in its filing.
Tagged under the XBRL concept onl:IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment.
The official record: Orion Office REIT’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment?
- Orion Office REIT (ONL) reported income (loss) from equity method investments and equity method investment, other-than-temporary impairment of -$2.96M in Q4 2025.
- How has Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment changed year-over-year?
- Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment decreased by 1497.6% year-over-year, from -$185K to -$2.96M.
- What is the long-term trend for Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment?
- Over 2 years (2023 to 2025), Orion Office REIT's income (loss) from equity method investments and equity method investment, other-than-temporary impairment has grown at a 421.3% compound annual growth rate (CAGR), from -$435K to -$11.82M.
- What does income (loss) from equity method investments and equity method investment, other-than-temporary impairment mean?
- This metric represents the company's proportional share of the net income or loss from investments in unconsolidated entities, including any impairment charges related to those interests. It is essential for understanding the performance and risk profile of the company's joint venture and partnership strategy.